Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Question for dummies

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Nov 08, 2022 8:03pm

103 Views

Post# 35083914

RE:RE:RE:Question for dummies

Ok market new when it sold in 2010 before Egrifta got approved... it new in 2018 before Trogarzo got approved... market new when it sold at 19 cents in 2013.... thet market got it very wrong about this company both ways up or down. SPCEO can tell you what he thinks the market has became in many respects.. it's a fu..ed-up world of algos and robinhooders... collective stupidity like the people getting crushed in football stadiums....

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions